The Lawyer’s new China Elite report contains the most detailed research available on the PRC legal market and contains unparalleled insight into the country's leading law firms. They vary in size, practice focus and geographic coverage, but they all share one common quality – ambition... Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
The long-serving general counsel of privately owned company Ferring Pharmaceutical has quit after the company relocated from Copenhagen to Wallisellen, Switzerland.
General counsel Patricia Barclay decided not to move with the company headquarters, which could leave Ferring without a general counsel for much of the year. She has been general counsel since 1984.
Ferring has an annual revenue of almost E600m (£413.6m) and around 2,500 employees. The replacement counsel will sit on the senior management team, reporting directly to chairman and founder Dr Frederick Paulsen. The general counsel is in charge of both the legal and patent/IP departments.
It is understood that, although applications have come in from private practice lawyers, Ferring would prefer to hire from competitors in the pharmaceutical market.
Ferring, which produces synthetic peptides for the manufacture of biopharmaceutical products, is understood to have invested E90m (£62m) in the construction of its new state-of-the-art Swiss headquarters.